This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Frost & Sullivan Acknowledges Euro Diagnostica AB's Excellence In Product Differentiation





LONDON, April 30, 2013 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics market, Frost & Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award.

"Euro Diagnostica offers a range of high-quality enzyme linked immunosorbent assay (ELISA) kits for autoimmune diagnostics," noted Frost & Sullivan Senior Research Analyst Srinivas Sashidhar. "Together with world class scientists Euro Diagnostica has been the first to develop and produce the gold standard testing for autoantibodies to citrullinated proteins/peptide (anti-CCP autoantibodies) for rheumatoid arthritis through its anti-CCP2 ELISA kit Immunoscan CCPlus ®."

In addition, Euro Diagnostica has been the first to develop anti-neutrophil cytoplasmic antibodies (ANCA) tests for diagnosing systemic vasculitis and related diseases. Wieslab ® Capture ANCA ELISA is based on the capture technique developed by Euro Diagnostica to better optimise antigen presentation.

"Clinical evaluation of capture assays for determining PR3 ANCA shows that this format has a higher diagnostic sensitivity for detecting patients with potentially life threatening granulomatosis with polyangiitis (GPA), compared with the direct coating method or indirect immunofluorescence," remarked Sashidhar.

Another unique product line is the Euro Diagnostica complement test system, Wieslab ® Complement ELISA that consists of functional assessments of all three pathways - classical, alternative and lectin - in a simple and accurate ELISA format. Assessment of the three pathways can be carried out with separate ELISA kits or in a combined kit.

Euro Diagnostica, as a partner of Dynex, has harmonised all ELISA tests to the DSX and DS2 platform. Earlier this year, the company also added EULISA tests to its existing product line for autoimmune diagnostics.

"All the diagnostic products developed by Euro Diagnostica are compatible and customised for clinical autoimmunology, microbiology, and immunochemistry laboratories," stated Sashidhar. "The Dynex instrument is an open and flexible diagnostic solution, which can be tailored for a range of autoimmune diseases, including localised and systemic diseases.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs